Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis

Peng Chen1 Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei

Fuchao Chen2 Department of Pharmacy, Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei

Benhong Zhou1 Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei;3 School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected]

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Grisma Patel, Monisha Edirisooriya, Moloy Dey & Rosemeen Parkar. (2023) Bilateral multifocal central serous retinopathy due to management of metastatic melanoma with BRAf MEK inhibitors: Case report. Current Problems in Cancer: Case Reports 9, pages 100208.
Crossref

Olamide T. Olaoba, Sultan Kadasah, Stefan W. Vetter & Estelle Leclerc. (2020) RAGE Signaling in Melanoma Tumors. International Journal of Molecular Sciences 21:23, pages 8989.
Crossref

Charles Dolladille, Jonaz Font, Theodora Bejan-Angoulvant, Khalil Zaman, Marion Sassier, Emilien Ezine, Andreea Stefan, Anne-Flore Plane, Damien Legallois, Paul Milliez, Jean-Jacques Parienti & Joachim Alexandre. (2020) Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis. Archives of Cardiovascular Diseases 113:6-7, pages 420-432.
Crossref

Marina Mojena, Adrián Povo-Retana, Silvia González-Ramos, Victoria Fernández-García, Javier Regadera, Arturo Zazpe, Inés Artaiz, Paloma Martín-Sanz, Francisco Ledo & Lisardo Boscá. (2018) Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells. Frontiers in Oncology 8.
Crossref

Rossella Salemi, Luca Falzone, Gabriele Madonna, Jerry Polesel, Diana Cinà, Domenico Mallardo, Paolo A. Ascierto, Massimo Libra & Saverio Candido. (2018) MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA. Frontiers in Pharmacology 9.
Crossref

Luca Tagliabue, Stefano Vassallo, Simona Malaspina & Andrea Luciani. (2018) Imaging melanoma: when and why. A proposal for a modern approach. Clinical and Translational Imaging 6:2, pages 123-134.
Crossref

Reinhard Dummer. (2018) BRAF -mutant Melanoma – The COLUMBUS Trial . European Oncology & Haematology 14:2, pages 78.
Crossref

Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date